Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NaZura BioHealth Inc.

Latest From NaZura BioHealth Inc.

Pronutria Gains $12.5 Million Funding For Protein Product Trials

The start-up developer of medical foods and supplements is conducting clinical trials on two candidates to stave off muscle loss in elderly people. The firm soon may begin development of therapeutic product candidates with a separate business unit.

BioPharmaceutical Consumer

Pronutria Gains $12.5 Million Funding For Protein Product Trials

The start-up developer of medical foods and supplements is conducting clinical trials on two candidates to stave off muscle loss in elderly people. The firm soon may begin development of therapeutic product candidates with a separate business unit.

BioPharmaceutical Consumer

J.P. Morgan Notebook: Monday, January 13

Welcome to “The Pink Sheet” DAILY’s round-up of news and notes from the first full day of the 2014 J.P. Morgan health care conference, including chats with the CEOs of Elcelyx Therapeutics and Arecor, news from Juno Therapeutics and Galena Biopharma, and more.

BioPharmaceutical Business Strategies

Start-Up Quarterly Statistics, Q3 2013

Start-up fundraising for Q3 2013 totaled $559.4 million, down from last quarter’s big rally ($907.2 million) but still up from the sluggish first quarter ($398.7 million). More than half of that money went to biopharma companies, a group which also received investments through alliances with equity provisions.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NaZura BioHealth Inc.
  • Senior Management
  • Alain D Baron, MD, Pres. & CEO
    Martin R Brown, SVP, Fin. & Ops.
    Mark S Fineman, PhD, SVP, R&D
    Mark Wiggins, SVP, Corp. & Bus. Dev.
  • Contact Info
  • NaZura BioHealth Inc.
    Phone: (858) 227-9233
    11995 El Camino Real, Ste. 305
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register